Page last updated: 2024-08-23

ursodeoxycholic acid and Hypertension, Pulmonary

ursodeoxycholic acid has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amuro, H; Ito, T; Nishizawa, T; Nomura, S; Ozaki, Y; Son, Y; Tamaki, T; Tanaka, A1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Hypertension, Pulmonary

ArticleYear
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.
    Journal of medical case reports, 2014, Jul-11, Volume: 8

    Topics: Aged; Bosentan; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Liver Function Tests; Middle Aged; Sulfonamides; Ursodeoxycholic Acid

2014